New applications for jobless benefits rose by 8,000 to 247,000 for the week ending May 31, the Department of Labor announced ...

Hims & Hers Health has seen massive success, aided by the growing use of GLP-1 drugs. Click here to find out why I downgrade ...

Hims & Hers accelerates European growth with new ZAVA acquisition, adding localized care and lab testing innovation.

One of the most exciting growth stories in the market is that of Hims & Hers Health Inc. (NYSE: HIMS). This company has ...

Today marks the first official agency warning about the possibility of these drugs—specifically Mounjaro—decreasing the ...

A month has gone by since the last earnings report for Omnicell (OMCL). Shares have added about 27% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...

As the United States stock market experiences modest gains amid ongoing trade negotiations and economic data releases, investors are keenly observing the potential impacts of these developments on ...